Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
Cancers | Free Full-Text | Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)